Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, Miller A, Lewis D, O'Donnell J, Chen L, Reinhart H, Srinivasan S, Isaacs R, Altarac D.
Lancet Infect Dis. 2023 Sep;23(9):1072-1084. doi: 10.1016/S1473-3099(23)00184-6. Epub 2023 May 11.
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation.
Mea HJ, Yong PVC, Wong EH.
Microbiol Res. 2021 Jun;247:126722. doi: 10.1016/j.micres.2021.126722. Epub 2021 Feb 4.
Pathogenesis of Gram-Negative Bacteremia.
Holmes CL, Anderson MT, Mobley HLT, Bachman MA.
Clin Microbiol Rev. 2021 Mar 10;34(2):e00234-20. doi: 10.1128/CMR.00234-20. Print 2021 Jun 16.
Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations.
Kubin CJ, Garzia C, Uhlemann A-C.
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0106324. doi: 10.1128/aac.01063-24. Epub 2025 Jul 9.
Acinetobacter infection.
Munoz-Price LS, Weinstein RA.
N Engl J Med. 2008 Mar 20;358(12):1271-81. doi: 10.1056/NEJMra070741.
Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii.
Higham SL, Baker S, Flight KE, Krishna A, Kellam P, Reece ST, Tregoning JS.
J Infect. 2023 Jun;86(6):563-573. doi: 10.1016/j.jinf.2023.02.035. Epub 2023 Feb 27.
[Acinetobacter].
Iinuma Y.
Nihon Rinsho. 2002 Nov;60(11):2161-5.
Acinetobacter.
Ristuccia PA, Cunha BA.
Infect Control. 1983 Jul-Aug;4(4):226-9. doi: 10.1017/s0195941700058276.
Septicemia due to Acinetobacter junii.
Linde HJ, Hahn J, Holler E, Reischl U, Lehn N.
J Clin Microbiol. 2002 Jul;40(7):2696-7. doi: 10.1128/JCM.40.7.2696-2697.2002.
Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice.
Bondareva NE, Soloveva AV, Sheremet AB, Koroleva EA, Kapotina LN, Morgunova EY, Luyksaar SI, Zayakin ES, Zigangirova NA.
J Antibiot (Tokyo). 2022 Mar;75(3):155-163. doi: 10.1038/s41429-022-00504-y. Epub 2022 Jan 21.
